The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter
about
A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressorHuman Slug is a repressor that localizes to sites of active transcriptionPotentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoproteinThe growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylasesPML colocalizes with and stabilizes the DNA damage response protein TopBP1Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.Sp2 localizes to subnuclear foci associated with the nuclear matrixActivation of the human PAX6 gene through the exon 1 enhancer by transcription factors SEF and Sp1PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodiesRelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actionsRole of ND10 nuclear bodies in the chromatin repression of HSV-1The function, regulation and therapeutic implications of the tumor suppressor protein, PMLThe transcriptional role of PML and the nuclear bodyPromyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactionsPML protein isoforms and the RBCC/TRIM motifPML interaction with p53 and its role in apoptosis and replicative senescenceThe promyelocytic leukemia protein represses A20-mediated transcriptionmSharp-1/DEC2, a basic helix-loop-helix protein functions as a transcriptional repressor of E box activity and Stra13 expressionThe pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease.Coregulator small nuclear RING finger protein (SNURF) enhances Sp1- and steroid receptor-mediated transcription by different mechanisms.Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer.The SANT domain of human MI-ER1 interacts with Sp1 to interfere with GC box recognition and repress transcription from its own promoter.Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot.Promoter-specific activation and demethylation by MBD2/demethylase.Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patientsEffects of promyelocytic leukemia protein on virus-host balance.PML-mediated signaling and its role in cancer stem cells.Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteinsTranscriptional regulation in acute promyelocytic leukemia.PODs in the nuclear spot: enigmas in the magician's pot.Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effectsInhibition of Sp1 functions by its sequestration into PML nuclear bodies.Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter.In vivo regulation of the heme oxygenase-1 gene in humanized transgenic miceThe promyelocytic leukemia zinc finger protein: two decades of molecular oncologyPromyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions.Nuclear domain 10-associated proteins recognize and segregate intranuclear DNA/protein complexes to negate gene expressionSignal-dependent regulation of transcription by histone deacetylase 7 involves recruitment to promyelocytic leukemia protein nuclear bodiesSp1 and the 'hallmarks of cancer'.Discovery and validation of information theory-based transcription factor and cofactor binding site motifs.
P2860
Q22253326-74F6E95D-8326-4606-A020-31F5EDA187E7Q22254334-67D4D89E-B559-4C24-A455-C52D2CEC4AC6Q22254766-194E0F54-6EA2-4568-B416-B452DFF3F0F7Q24290948-CBF307A1-34B7-4DE1-A33E-5383B5677DA9Q24303540-1CD8B85A-E6AA-41E2-9009-D6AB0E27A271Q24529191-828ED7DF-E238-41C9-9867-532284BAF293Q24541557-2714B32A-74F1-4B7E-86E8-31EBDC8E502DQ24555121-D874ED77-51A7-47A9-885D-FF0405F6CC09Q24599898-DAE568BF-C9AF-4546-807F-F10EFDF92C8DQ24673698-CD9CC715-DC5E-4BB4-8CF9-0212BE167949Q26751443-C826DB58-51CC-44C0-865C-D9AFF17AE49EQ26779358-24EAB0B4-0BF5-424B-85C8-6660044CBBFFQ28144176-368809F0-BFB3-487B-A01F-60B28D56A191Q28200940-4AFE6ADF-65BF-47DE-B402-0604485390A9Q28204823-CDB81E87-BCA1-49E3-B2F1-C5B6EC7E711DQ28204830-754D9CBB-B695-4342-A72B-0A0A0FC62D07Q28206387-01228D86-3A7F-464C-A34A-5E6D9B803034Q28593300-6DEE7C79-4D83-4152-B3C5-F4D4BA1B0FC4Q33723609-F8835A50-69A5-48D9-AACA-4F8C3FFF8D95Q33885302-DB7C7394-FA15-4EE5-A66E-992C6FF01FBFQ33952921-496FB5F9-7846-4AB2-9860-11E4A20AD497Q33977927-4AB327CE-6D38-4A67-B7E0-3766610B6CBBQ34101415-076B6496-7921-4CFB-8C79-BC77740F6326Q34144453-B8CDA222-A75F-4728-BB8E-3AB48BACBABEQ34267949-3E26AB5E-F328-472C-8755-C965A53BA502Q34335521-2E773557-84CB-4A62-AC06-5F1AC4DF2E29Q34337626-1587F157-3012-4CBC-96CC-BBE2265599B0Q34345244-C63D4491-9965-403A-804C-D1B60A0F7B2FQ34435531-7B30BC4A-E71D-40D6-A76A-C076F44F38C7Q34467958-2E9FA291-1A67-424D-83F3-D3E4C6E2A31DQ35020024-02584EB8-F729-45A5-8CFA-33CD98B10346Q35146908-28EEC01D-F4CF-48C6-A442-2E716F76A814Q35875014-B2F11311-6DC8-4828-BC89-61E7EC7214CFQ36094903-65ACA17B-6B15-41E9-8AFF-2ED46BCCF578Q36099642-913E9DF2-A928-4F9F-82F7-48F88A9083C8Q36321821-57B4A5E9-3546-4D8A-A81C-BB8F613AC8A3Q36412174-FE4DBB75-A61B-4585-B900-E5E4C2BB476AQ36739964-4C8A7341-5ACC-457E-8FA8-3DB7F64B9193Q38267908-D77E6C1F-7796-4693-A6A9-2AB2CF92465AQ38289980-60AE2067-813F-4FA3-A5A9-5073A2D2EA28
P2860
The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@ast
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@en
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@en-gb
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@nl
type
label
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@ast
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@en
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@en-gb
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@nl
prefLabel
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@ast
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@en
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@en-gb
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@nl
P2093
P2860
P3181
P356
P1476
The promyelocytic leukemia pro ...... rowth factor receptor promoter
@en
P2093
P2860
P304
P3181
P356
10.1128/MCB.18.12.7147
P407
P577
1998-12-01T00:00:00Z